Skip to search.
 FTSE 100 Up 0.62%
Streaming
Ticker Tape: On

Alkermes plc (ALKS)

-NasdaqGS
44.12 Down 0.91(2.02%) 17 Apr 21:00
|After Hours: : 44.12 0.00 (0.00%) 17 Apr 21:29
Add to Portfolio
Prev Close:45.03
Open:44.78
Bid:41.77 x 100
Ask:50.00 x 600
1y Target Est:50.55
Beta:1.39
Next Earnings Date:N/A
Day's Range:44.03 - 45.72
52wk Range:26.47 - 54.25
Volume:1,068,231
Avg Vol (3m):1,359,940
Market Cap:6.36b
P/E (ttm):275.75
EPS (ttm):0.16
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 2.02%6.36b
ABTUp 1.43%60.07b
LLYUp 0.78%64.47b
GSKDown 0.59%125.79b

Key Statistics

Forward P/E (1 yr):58.05
P/S (ttm):11.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.50
Quarterly EPS Est (Mar-14) :0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback